Free Trial

Abeona Therapeutics (ABEO) Competitors

$4.57
-0.02 (-0.44%)
(As of 06/14/2024 ET)

ABEO vs. QURE, ACRS, EQ, LUMO, ACRX, LBPH, NUVB, EOLS, OLMA, and PAHC

Should you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include uniQure (QURE), Aclaris Therapeutics (ACRS), Equillium (EQ), Lumos Pharma (LUMO), AcelRx Pharmaceuticals (ACRX), Longboard Pharmaceuticals (LBPH), Nuvation Bio (NUVB), Evolus (EOLS), Olema Pharmaceuticals (OLMA), and Phibro Animal Health (PAHC). These companies are all part of the "pharmaceutical preparations" industry.

Abeona Therapeutics vs.

Abeona Therapeutics (NASDAQ:ABEO) and uniQure (NASDAQ:QURE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Abeona Therapeutics presently has a consensus target price of $21.00, suggesting a potential upside of 359.52%. uniQure has a consensus target price of $24.75, suggesting a potential upside of 406.13%. Given uniQure's higher probable upside, analysts clearly believe uniQure is more favorable than Abeona Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abeona Therapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
uniQure
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Abeona Therapeutics has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500. Comparatively, uniQure has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.

Abeona Therapeutics has a net margin of 0.00% compared to uniQure's net margin of -1,562.22%. uniQure's return on equity of -121.60% beat Abeona Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Abeona TherapeuticsN/A -543.60% -78.51%
uniQure -1,562.22%-121.60%-34.76%

In the previous week, Abeona Therapeutics had 4 more articles in the media than uniQure. MarketBeat recorded 5 mentions for Abeona Therapeutics and 1 mentions for uniQure. uniQure's average media sentiment score of 1.89 beat Abeona Therapeutics' score of 1.12 indicating that uniQure is being referred to more favorably in the news media.

Company Overall Sentiment
Abeona Therapeutics Positive
uniQure Very Positive

Abeona Therapeutics has higher earnings, but lower revenue than uniQure. Abeona Therapeutics is trading at a lower price-to-earnings ratio than uniQure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abeona Therapeutics$3.50M53.48-$54.19M-$3.20-1.43
uniQure$15.84M14.99-$308.48M-$6.21-0.79

80.6% of Abeona Therapeutics shares are owned by institutional investors. Comparatively, 78.8% of uniQure shares are owned by institutional investors. 5.3% of Abeona Therapeutics shares are owned by company insiders. Comparatively, 4.7% of uniQure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

uniQure received 122 more outperform votes than Abeona Therapeutics when rated by MarketBeat users. Likewise, 70.70% of users gave uniQure an outperform vote while only 70.36% of users gave Abeona Therapeutics an outperform vote.

CompanyUnderperformOutperform
Abeona TherapeuticsOutperform Votes
515
70.36%
Underperform Votes
217
29.64%
uniQureOutperform Votes
637
70.70%
Underperform Votes
264
29.30%

Summary

Abeona Therapeutics and uniQure tied by winning 9 of the 18 factors compared between the two stocks.

Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABEO vs. The Competition

MetricAbeona TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$187.19M$6.92B$5.20B$8.39B
Dividend YieldN/A2.73%2.81%4.04%
P/E Ratio-1.4321.84150.9518.08
Price / Sales53.48385.202,236.7389.33
Price / CashN/A31.5534.9631.18
Price / Book7.625.544.874.22
Net Income-$54.19M$146.89M$110.98M$216.24M
7 Day Performance7.03%0.77%-0.44%-0.46%
1 Month Performance-0.65%-3.05%-2.76%-2.37%
1 Year Performance1.56%-7.60%-0.44%1.57%

Abeona Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QURE
uniQure
1.7201 of 5 stars
$5.22
-0.2%
$24.75
+374.1%
-74.3%$253.43M$15.84M-0.84480Positive News
ACRS
Aclaris Therapeutics
2.7733 of 5 stars
$1.15
+2.7%
$22.25
+1,834.8%
-88.1%$81.95M$31.25M-1.0686Insider Buying
News Coverage
EQ
Equillium
2.2317 of 5 stars
$0.72
-1.0%
$3.90
+441.7%
-1.4%$25.38M$36.08M-2.0044
LUMO
Lumos Pharma
2.1901 of 5 stars
$2.57
+0.8%
$18.00
+600.4%
-35.4%$20.87M$2.05M-0.5633
ACRX
AcelRx Pharmaceuticals
1.1704 of 5 stars
N/A$4.63
+∞
N/A$14.58M$1.77M-0.3919Analyst Forecast
Gap Down
LBPH
Longboard Pharmaceuticals
2.1764 of 5 stars
$18.81
-1.4%
$42.57
+126.3%
+138.7%$731.33MN/A-8.4050Analyst Forecast
Analyst Revision
News Coverage
NUVB
Nuvation Bio
3.6642 of 5 stars
$2.92
+2.5%
$6.60
+126.0%
+71.6%$721.74MN/A-9.42159Insider Buying
Short Interest ↑
News Coverage
Positive News
Gap Up
EOLS
Evolus
3.5636 of 5 stars
$11.52
-0.5%
$21.67
+88.1%
+47.3%$721.15M$202.09M-10.97279Gap Up
OLMA
Olema Pharmaceuticals
1.9719 of 5 stars
$12.83
-5.8%
$22.00
+71.5%
+36.1%$717.58MN/A-6.3574Gap Up
PAHC
Phibro Animal Health
3.8695 of 5 stars
$17.61
+5.1%
$14.75
-16.2%
+25.5%$713.21M$977.90M55.031,920Positive News

Related Companies and Tools

This page (NASDAQ:ABEO) was last updated on 6/16/2024 by MarketBeat.com Staff

From Our Partners